Hendrik Koffijberg

Heidelberg University, University of Twente

Papers

2

Total Citations

198

H-Index

2

About

Hendrik Koffijberg is a leading researcher in clinical decision modeling and health technology assessment, with a focus on improving surgical and diagnostic strategies for cancer patients. His work bridges the gap between complex clinical data and actionable insights, particularly in esophageal and prostate cancer. Koffijberg’s major contributions include co-authoring the landmark ROBOT trial (179 citations), which demonstrated the benefits of robot-assisted minimally invasive esophagectomy over open surgery for resectable esophageal cancer, influencing surgical practice worldwide. He also advanced prostate cancer care by externally validating the Memorial Sloan Kettering and Briganti nomograms (19 citations), showing how MRI-based clinical staging can improve predictions of lymph node involvement—a key step in personalizing treatment. His research emphasizes rigorous validation and real-world applicability, with high-impact studies that shape clinical guidelines. Koffijberg’s work is essential for students and researchers interested in evidence-based surgery, predictive modeling, and the integration of innovative technologies into oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
198
Total Citations
99
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial)
179 citations · 2012
📈 Most Prolific Year: 2012 (1 Papers)
🤝 Key Collaborators: 31
🏛 Institutions: Heidelberg University, University of Twente

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago